risedronic acid has been researched along with Oroantral Fistula in 2 studies
Risedronic Acid: A pyridine and diphosphonic acid derivative that acts as a CALCIUM CHANNEL BLOCKER and inhibits BONE RESORPTION.
Oroantral Fistula: A fistula between the maxillary sinus and the oral cavity.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bornstein, MM | 1 |
| Oberli, K | 1 |
| Stauffer, E | 1 |
| Buser, D | 1 |
| Brooks, JK | 1 |
| Gilson, AJ | 1 |
| Sindler, AJ | 1 |
| Ashman, SG | 1 |
| Schwartz, KG | 1 |
| Nikitakis, NG | 1 |
1 review available for risedronic acid and Oroantral Fistula
| Article | Year |
|---|---|
[Biphosphonate-associated osteonecrosis of the maxilla. Case report and review of the literature].
Topics: Administration, Oral; Aged, 80 and over; Bone Density Conservation Agents; Diphosphonates; Etidronic | 2006 |
1 other study available for risedronic acid and Oroantral Fistula
| Article | Year |
|---|---|
Osteonecrosis of the jaws associated with use of risedronate: report of 2 new cases.
Topics: Administration, Oral; Aged; Bone Density Conservation Agents; Dental Implantation, Endosseous; Etidr | 2007 |